UK firm gets grant for electronic DNA technology:
This article was originally published in Clinica
Executive Summary
The UK's LINK programme for Applied Genomics has awarded Molecular Sensing a £347,000 ($562,000) grant to develop clinical microbiology diagnostics based on the firm's electronic DNA detection system. The system, says the Wiltshire, UK company, is particularly advantageous where rapid diagnosis of a disease can significantly benefit the patient. For example, meningitis can prove fatal if undiagnosed and untreated in the first 72 hours. However, current methods involving microscopy or culturing of bacteria are slow, require significant expertise and are often inconclusive.